YBX1 and neoplasm: YBX1 has been identified as a pivotal m5C reader protein that regulates the stability or translation efficiency of target RNA in various cancer types, and we found that LUAD patients with high YBX1 expression have a significantly lower overall survival rate in tumor stage III and IV (Fig. S1B).